Predictive Oncology Shares Are Trading Higher After the Company Announced a Collaboration With FluGen for an Intranasal Flu Vaccine.
Predictive Oncology Shares Are Trading Higher After the Company Announced a Collaboration With FluGen for an Intranasal Flu Vaccine.
在該公司宣佈與FluGen合作開發鼻內流感疫苗後，預測腫瘤學股價走高。
Predictive Oncology Shares Are Trading Higher After the Company Announced a Collaboration With FluGen for an Intranasal Flu Vaccine.
在該公司宣佈與FluGen合作開發鼻內流感疫苗後，預測腫瘤學股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。